Pfizer (PFE) and Valneva (VALN) said the EMA has validated their Marketing Authorization Application for PF-07307405, enabling the regulator to start its assessment for their Lyme disease vaccine candidate. The validation is a positive regulatory milestone that supports progress toward potential approval.
Pfizer (PFE) and Valneva (VALN) said the EMA has validated their Marketing Authorization Application for PF-07307405, enabling the regulator to start its assessment for their Lyme disease vaccine candidate. The validation is a positive regulatory milestone that supports progress toward potential approval.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
mildly positive
Sentiment Score
0.35
Ticker Sentiment
